U
CYTR

UBS’s CytRx Corp CYTR Stock Holding History

UBS’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6K Sell
383
-567
-60% -$11.2K ﹤0.01% 9400
2014
Q2 		$24K Buy
+950
New +$21.7K ﹤0.01% 7876
2014
Q1 		– Sell
-883
Closed -$33K – 11459
2013
Q4 		$33K Buy
883
+216
+32% +$3.93K ﹤0.01% 7540
2013
Q3 		$13K Buy
+667
New +$9.83K ﹤0.01% 8616

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

UBS's CYTR Position: Q3 2014 in Review

UBS increased its CytRx Corp (CYTR) stake by 30% in Q3 2014, buying an estimated $1.17K and bringing the position to 258 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #9731.

UBS first reported a position in CYTR in Q2 2013 and has held it in 6 quarters since. The position peaked at $460K in Q1 2014. 69 funds tracked by Wall St. Rank hold CYTR as of Q3 2014.

  • UBS held 258 shares of CytRx Corp worth $4K as of Q3 2014.
  • UBS bought 59 CytRx Corp shares in Q3 2014, an estimated $1.17K.
  • CytRx Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9731 holding.
  • UBS first reported a position in CytRx Corp in Q2 2013 and has held it in 6 quarters since.
  • UBS's CytRx Corp position peaked at $460K in Q1 2014.
  • 69 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.